| 1 |
Editorial Immunosuppression for autoimmune retinopathy. 2009
Jampol LM, Fishman GA. · No affiliation provided · Arch Ophthalmol. · Pubmed #19365043 No free full text.
This publication has no abstract.
|
| 2 |
Editorial AREDS--two years later. 2003
Jampol LM. · No affiliation provided · Arch Ophthalmol. · Pubmed #14609925 No free full text.
This publication has no abstract.
|
| 3 |
Editorial Treatment of juxtafoveal and extrafoveal choroidal neovascularization in the era of photodynamic therapy with verteporfin. 2002
Jampol LM, Scott L. · No affiliation provided · Am J Ophthalmol. · Pubmed #12095815 No free full text.
This publication has no abstract.
|
| 4 |
Editorial Antioxidants, zinc, and age-related macular degeneration: results and recommendations. 2001
Jampol LM. · No affiliation provided · Arch Ophthalmol. · Pubmed #11594957 No free full text.
This publication has no abstract.
|
| 5 |
Article Treatment of choroidal neovascularization in AMD. 2006
Weinberg DV, Jampol LM. · No affiliation provided · Ophthalmology. · Pubmed #17157142 No free full text.
This publication has no abstract.
|
| 6 |
Article Antioxidants and zinc to prevent progression of age-related macular degeneration. 2001
Jampol LM. · Department of Ophthalmology, Northwestern University Medical School, 645 N Michigan Ave, Suite 440, Chicago, IL 60611, USA. · JAMA. · Pubmed #14619914 No free full text.
This publication has no abstract.
|
| 7 |
Article Antioxidants and zinc to prevent progression of age-related macular degeneration. 2001
Jampol LM, Ferris FL. · Department of Ophthalmology, Northwestern University Medical School, Chicago, IL 60611, USA. · JAMA. · Pubmed #11759670 No free full text.
This publication has no abstract.
|
| 8 |
Article Coats'-like response in pars planitis. 1999
Suh DW, Pulido JS, Jampol LM, Chong LP, Thomas M. · Eye Institute, Medical College of Wisconsin, Milwaukee, USA. · Retina. · Pubmed #10048380 No free full text.
This publication has no abstract.
|
| 9 |
Minor Neovascular age-related macular degeneration: roundtable. 2005
Singerman LJ, Brucker AJ, Jampol LM, Lim JI, Rosenfeld P, Schachat AP, Spaide RF. · Retina Associates of Cleveland, Cleveland, OH, USA. · Retina. · Pubmed #16208185 No free full text.
Abstract: Several recent developments may provide an opportunity to improve outcome in individuals who develop neovascular age-related maculopathy (age-related macular degeneration [ARMD]). Concurrent with progress in isolating clinically relevant subtypes of neovascular ARMD, several therapies have been introduced that show promise for halting progression of this disorder. However, data from controlled clinical trials to test the relative efficacy of different management strategies across these subtypes of disease presentation remain limited. In addition, strategies to control ARMD may evolve quickly as more is learned about how specific molecular events, such as cell-mediated inflammation and angiogenesis, contribute to disease expression. A roundtable of investigators was convened to discuss and summarize recent progress in the treatment of ARMD. Case studies were then presented to provide an opportunity for experts to reveal their specific thought processes in the approach to neovascular ARMD based on their own interpretation of current clinical data and empirical experience.
|
|
|